Alithea Biotechnology at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Alithea Biotechnology takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 553. Its program centres on making cancer immunotherapy safer and more effective. The session presents its liquid biopsy and AI platforms built for that purpose.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
alithea-bio.com
CRO, CDMO & labsAssociate sponsor
Specialises in quantifying HLA-presented peptides, with liquid biopsy and AI platforms supporting safer, more effective immunotherapies.
Booth
Exhibiting at Booth 553
Talk
Mon Oct 19
11:15
Enabling Safe and Effective Cancer Immunotherapy: through Alithea’s liquid biopsy and AI Platforms
Workshop: Cancer & Therapeutic Vaccines

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alithea Biotechnology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction